Advanced search
Start date
Betweenand
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Diagnostic performance and clinical associations of antibodies to the chromatin antigenic system in juvenile systemic lupus erythematosus

Full text
Author(s):
Silene Peres Keusseyan [1] ; Neusa Pereira da Silva [2] ; Maria Odete Esteves Hilário [3] ; Eunice Mitiko Okuda [4] ; Maria Teresa S. L. R. Ascenção Terreri ; Luis Eduardo Coelho Andrade [6]
Total Authors: 6
Affiliation:
[1] Universidade Federal de São Paulo
[2] Universidade Federal de São Paulo
[3] Universidade Federal de São Paulo
[4] Santa Casa de Misericórdia de São Paulo. Faculdade de Ciências Médicas
[6] Universidade Federal de São Paulo
Total Affiliations: 6
Document type: Journal article
Source: REVISTA BRASILEIRA DE REUMATOLOGIA; v. 52, n. 5, p. 703-712, 2012-10-00.
Abstract

OBJECTIVES: To determine the frequency of antibodies to chromatin components in juvenile systemic lupus erythematosus (JSLE), and to correlate the presence of these autoantibodies with clinical manifestations and disease activity. METHODS: Anti-chromatin (anti-CHR), anti-nucleosome core particle (anti-NCS) and anti-dsDNA antibodies were measured in 175 individuals, including 37 patients with active JSLE and 41 with inactive disease, 47 non-lupus autoimmune disease patients (non-lupus AD), and 50 healthy children. An in-house ELISA was developed with purified nucleosome core particles from calf thymus to determine IgG and IgG3 anti-NCS antibodies. Anti-CHR and anti-dsDNA antibodies were detected by commercial ELISA kits (INOVA). RESULTS: Anti-NCS and anti-CHR antibodies exhibited high specificity for JSLE and similar frequency in active and inactive JSLE. Anti-CHR and IgG/IgG3 anti-NCS serum levels did not differ between active and inactive JSLE. SLEDAI correlated with anti-dsDNA antibodies but not with antibodies to other chromatin components. There was association of anti-dsDNA, anti-CHR and IgG/IgG3 anti-NCS antibodies with proteinuria and low C4 serum levels. Anti-NCS antibodies in the absence of anti-dsDNA were observed in 14% of the JSLE patients. CONCLUSIONS: Our data indicate that anti-NCS and anti-CHR antibodies are relevant diagnostic markers for JSLE and appear to be correlated with JSLE lupus nephritis activity. IgG3 isotype anti-NCS antibodies do not seem to be more relevant than IgG anti-NCS antibodies as markers of disease activity or active nephritis in JSLE. (AU)

FAPESP's process: 05/00658-0 - Diagnostic performace and clinical associations of antinucleosome antibodies in juvenile systemic lupus erythematosus
Grantee:Luiz Eduardo Coelho Andrade
Support Opportunities: Regular Research Grants